{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:30:23Z","timestamp":1794029423303,"version":"4.8.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700295"],"award-info":[{"award-number":["81700295"]}],"id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Atrial remodeling is the main developmental cause of atrial arrhythmias (AA), which may induce atrial fibrillation, atrial flutter, atrial tachycardia, and frequent premature atrial beats in acute myocardial infarction (AMI) patients. Thrombospondin-1 (TSP-1) has been shown to play an important role in inflammatory and fibrotic processes, but its role in atrial arrhythmias is not well described. The purpose of this study was to investigate the role of TSP-1 in AMI patients with atrial arrhythmias.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 219 patients with AMI who underwent percutaneous coronary intervention and with no previous arrhythmias were included. TSP-1 were analyzed in plasma samples. Patients were classified into 2 groups, namely, with and without AA during the acute phase of MI. Continuous electrocardiographic monitoring was used for AA diagnosis in hospital.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty-four patients developed AA. Patients with AA had higher TSP-1 levels (29.01\u2009\u00b1\u200925.87\u00a0\u03bcg\/mL vs 18.36\u2009\u00b1\u200910.89\u00a0\u03bcg\/mL, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) than those without AA. AA patients also tended to be elderly (65.25\u2009\u00b1\u20099.98\u00a0years vs 57.47\u2009\u00b1\u200910.78\u00a0years, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), had higher Hs-CRP (39.74\u2009\u00b1\u200943.50\u00a0mg\/L vs 12.22\u2009\u00b1\u200919.25\u00a0mg\/L, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and worse heart function. TSP-1 (OR 1.033; 95% CI 1.003\u20131.065, <jats:italic>p<\/jats:italic>\u2009=\u20090.034), Hs-CRP (OR 1.023; 95% CI 1.006\u20131.041, <jats:italic>p<\/jats:italic>\u2009=\u20090.008), age (OR 1.067; 95% CI 1.004\u20131.135, <jats:italic>p<\/jats:italic>\u2009=\u20090.038) and LVDd (OR 1.142; 95% CI 1.018\u20131.282, <jats:italic>p<\/jats:italic>\u2009=\u20090.024) emerged as independent risk factors for AA in AMI patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>TSP-1 is a potential novel indicator of atrial arrhythmias during AMI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12872-021-02322-w","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T11:31:08Z","timestamp":1634729468000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Association of atrial arrhythmias with thrombospondin-1 in patients with acute myocardial infarction"],"prefix":"10.1186","volume":"21","author":[{"given":"Wenkai","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxia","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"issue":"3","key":"2322_CR1","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jacc.2015.05.018","volume":"66","author":"BS Larsen","year":"2015","unstructured":"Larsen BS, Kumarathurai P, Falkenberg J, Nielsen OW, Sajadieh A. Excessive atrial ectopy and short atrial runs increase the risk of stroke beyond incident atrial fibrillation. J Am Coll Cardiol. 2015;66(3):232\u201341.","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"2322_CR2","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.jacc.2020.02.025","volume":"75","author":"MK Chung","year":"2020","unstructured":"Chung MK, Refaat M, Shen WK, Kutyifa V, Cha YM, Di Biase L, Baranchuk A, Lampert R, Natale A, Fisher J, et al. Atrial fibrillation: JACC council perspectives. J Am Coll Cardiol. 2020;75(14):1689\u2013713.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"2322_CR3","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1161\/CIRCULATIONAHA.110.986661","volume":"123","author":"P Jabre","year":"2011","unstructured":"Jabre P, Roger VL, Murad MH, Chamberlain AM, Prokop L, Adnet F, Jouven X. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis. Circulation. 2011;123(15):1587\u201393.","journal-title":"Circulation"},{"issue":"12","key":"2322_CR4","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.recesp.2017.10.048","volume":"70","author":"B Ibanez","year":"2017","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Rev Esp Cardiol (Engl Ed). 2017;70(12):1082.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"8","key":"2322_CR5","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.jacc.2007.08.066","volume":"51","author":"AL Waldo","year":"2008","unstructured":"Waldo AL, Feld GK. Inter-relationships of atrial fibrillation and atrial flutter mechanisms and clinical implications. J Am Coll Cardiol. 2008;51(8):779\u201386.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2322_CR6","doi-asserted-by":"publisher","first-page":"e001733","DOI":"10.1161\/JAHA.114.001733","volume":"4","author":"C Ozcan","year":"2015","unstructured":"Ozcan C, Battaglia E, Young R, Suzuki G. LKB1 knockout mouse develops spontaneous atrial fibrillation and provides mechanistic insights into human disease process. J Am Heart Assoc. 2015;4(3):e001733.","journal-title":"J Am Heart Assoc"},{"key":"2322_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.matbio.2017.12.009","volume":"68\u201369","author":"JE Murphy-Ullrich","year":"2018","unstructured":"Murphy-Ullrich JE, Suto MJ. Thrombospondin-1 regulation of latent TGF-\u03b2 activation: a therapeutic target for fibrotic disease. Matrix Biol. 2018;68\u201369:28\u201343.","journal-title":"Matrix Biol"},{"key":"2322_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev.cellbio.17.1.25","volume":"17","author":"JC Adams","year":"2001","unstructured":"Adams JC. Thrombospondins: multifunctional regulators of cell interactions. Annu Rev Cell Dev Biol. 2001;17:25\u201351.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2322_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.matbio.2014.02.001","volume":"37","author":"O Stenina-Adognravi","year":"2014","unstructured":"Stenina-Adognravi O. Invoking the power of thrombospondins: regulation of thrombospondins expression. Matrix Biol. 2014;37:69\u201382.","journal-title":"Matrix Biol"},{"key":"2322_CR10","doi-asserted-by":"publisher","first-page":"296069","DOI":"10.1155\/2011\/296069","volume":"2011","author":"Z Lopez-Dee","year":"2011","unstructured":"Lopez-Dee Z, Pidcock K, Gutierrez LS. Thrombospondin-1: multiple paths to inflammation. Mediators Inflamm. 2011;2011:296069.","journal-title":"Mediators Inflamm"},{"key":"2322_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ijcard.2018.10.020","volume":"287","author":"L Scott Jr","year":"2019","unstructured":"Scott L Jr, Li N, Dobrev D. Role of inflammatory signaling in atrial fibrillation. Int J Cardiol. 2019;287:195\u2013200.","journal-title":"Int J Cardiol"},{"issue":"8","key":"2322_CR12","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.3390\/ijms22084062","volume":"22","author":"A Kale","year":"2021","unstructured":"Kale A, Rogers NM, Ghimire K. Thrombospondin-1 CD47 signaling: from mechanisms to medicine. Int J Mol Sci. 2021;22(8):4062.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2322_CR13","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.jacc.2018.12.074","volume":"73","author":"S Ravassa","year":"2019","unstructured":"Ravassa S, Ballesteros G, Lopez B, Ramos P, Bragard J, Gonzalez A, Moreno MU, Querejeta R, Vives E, Garcia-Bolao I, et al. Combination of circulating type I collagen-related biomarkers is associated with atrial fibrillation. J Am Coll Cardiol. 2019;73(12):1398\u2013410.","journal-title":"J Am Coll Cardiol"},{"key":"2322_CR14","doi-asserted-by":"publisher","first-page":"662914","DOI":"10.3389\/fcvm.2021.662914","volume":"8","author":"SPT Fong","year":"2021","unstructured":"Fong SPT, Agrawal S, Gong M, Zhao J. Modulated calcium homeostasis and release events under atrial fibrillation and its risk factors: a meta-analysis. Front Cardiovasc Med. 2021;8:662914.","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"2322_CR15","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/clc.22780","volume":"40","author":"BT Huang","year":"2017","unstructured":"Huang BT, Huang FY, Peng Y, Liao YB, Chen F, Xia TL, Pu XB, Chen M. Relation of premature atrial complexes with stroke and death: systematic review and meta-analysis. Clin Cardiol. 2017;40(11):962\u20139.","journal-title":"Clin Cardiol"},{"issue":"3","key":"2322_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233\u201370.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"5","key":"2322_CR17","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.cjca.2021.01.018","volume":"37","author":"M Aguilar","year":"2021","unstructured":"Aguilar M, Heijman J, Dobrev D, Nattel S. One ring to rule them all: continuous monitoring of patients with secondary atrial fibrillation points to a unifying underlying mechanism. Can J Cardiol. 2021;37(5):686\u20139.","journal-title":"Can J Cardiol"},{"issue":"6","key":"2322_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/CRD.0000000000000162","volume":"25","author":"AS Manolis","year":"2017","unstructured":"Manolis AS. Contemporary diagnosis and management of atrial flutter: a continuum of atrial fibrillation and vice versa? Cardiol Rev. 2017;25(6):289\u201397.","journal-title":"Cardiol Rev"},{"issue":"17","key":"2322_CR19","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1161\/CIRCULATIONAHA.109.874982","volume":"121","author":"Z Binici","year":"2010","unstructured":"Binici Z, Intzilakis T, Nielsen OW, Kober L, Sajadieh A. Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke. Circulation. 2010;121(17):1904\u201311.","journal-title":"Circulation"},{"issue":"532","key":"2322_CR20","doi-asserted-by":"publisher","first-page":"eaar2566","DOI":"10.1126\/scisignal.aar2566","volume":"11","author":"S Rosini","year":"2018","unstructured":"Rosini S, Pugh N, Bonna AM, Hulmes DJS, Farndale RW, Adams JC. Thrombospondin-1 promotes matrix homeostasis by interacting with collagen and lysyl oxidase precursors and collagen cross-linking sites. Sci Signal. 2018;11(532):eaar2566.","journal-title":"Sci Signal"},{"issue":"41","key":"2322_CR21","doi-asserted-by":"publisher","first-page":"32167","DOI":"10.1074\/jbc.M003834200","volume":"275","author":"K Bein","year":"2000","unstructured":"Bein K, Simons M. Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity. J Biol Chem. 2000;275(41):32167\u201373.","journal-title":"J Biol Chem"},{"issue":"1","key":"2322_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00059-015-4335-y","volume":"41","author":"NE Procter","year":"2016","unstructured":"Procter NE, Ball J, Ngo DT, Chirkov YY, Isenberg JS, Hylek EM, Stewart S, Horowitz JD. Platelet hyperaggregability in patients with atrial fibrillation. Evidence of a background proinflammatory milieu. Herz. 2016;41(1):57\u201362.","journal-title":"Herz"},{"key":"2322_CR23","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.omtn.2020.09.041","volume":"22","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Ng DYE, Richards AM, Wang P. microRNA-221 inhibits latent TGF-beta1 activation through targeting thrombospondin-1 to attenuate kidney failure-induced cardiac fibrosis. Mol Ther Nucleic Acids. 2020;22:803\u201314.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"22","key":"2322_CR24","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1161\/CIRCULATIONAHA.104.510354","volume":"111","author":"NG Frangogiannis","year":"2005","unstructured":"Frangogiannis NG, Ren G, Dewald O, Zymek P, Haudek S, Koerting A, Winkelmann K, Michael LH, Lawler J, Entman ML. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation. 2005;111(22):2935\u201342.","journal-title":"Circulation"},{"issue":"1","key":"2322_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3233\/CH-2012-1565","volume":"54","author":"R Kaiser","year":"2013","unstructured":"Kaiser R, Grotemeyer K, Kalsch T, Graber S, Wilkens H, Elmas E. Decreased TSP-1 following percutaneous coronary intervention is associated with major adverse cardiac events in ST-elevation myocardial infarction. Clin Hemorheol Microcirc. 2013;54(1):59\u201373.","journal-title":"Clin Hemorheol Microcirc"},{"issue":"4","key":"2322_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.5603\/CJ.a2018.0030","volume":"26","author":"R Befekadu","year":"2019","unstructured":"Befekadu R, Christiansen K, Larsson A, Grenegard M. Increased plasma cathepsin S and trombospondin-1 in patients with acute ST-segment elevation myocardial infarction. Cardiol J. 2019;26(4):385\u201393.","journal-title":"Cardiol J"},{"issue":"11","key":"2322_CR27","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.3390\/jcm9113677","volume":"9","author":"L Min-Tsun","year":"2020","unstructured":"Min-Tsun L, Chun-Kai C, Ting-Tse L, Li-Ying C, Hung-Wen T, Yen-Bin L. High-sensitivity C-reactive protein is a predictor of subsequent atrial high-rate episodes in patients with pacemakers and preserved ejection fraction. J Clin Med. 2020;9(11):3677.","journal-title":"J Clin Med"},{"issue":"9989","key":"2322_CR28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","volume":"386","author":"RB Schnabel","year":"2015","unstructured":"Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015;386(9989):154\u201362.","journal-title":"Lancet"},{"issue":"23","key":"2322_CR29","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","volume":"107","author":"TJ Wang","year":"2003","unstructured":"Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D\u2019Agostino RB, Murabito JM, Kannel WB, Benjamin EJ. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107(23):2920\u20135.","journal-title":"Circulation"},{"key":"2322_CR30","doi-asserted-by":"publisher","first-page":"i4482","DOI":"10.1136\/bmj.i4482","volume":"354","author":"A Odutayo","year":"2016","unstructured":"Odutayo A, Wong CX, Hsiao AJ, Hopewell S, Altman DG, Emdin CA. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ. 2016;354:i4482.","journal-title":"BMJ"},{"key":"2322_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.atherosclerosis.2020.08.026","volume":"312","author":"SL Harrison","year":"2020","unstructured":"Harrison SL, Lane DA, Banach M, Mastej M, Kasperczyk S, Jozwiak JJ, Lip GYH, Investigators L. Lipid levels, atrial fibrillation and the impact of age: results from the LIPIDOGRAM2015 study. Atherosclerosis. 2020;312:16\u201322.","journal-title":"Atherosclerosis"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02322-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-021-02322-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02322-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T08:11:29Z","timestamp":1635235889000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-021-02322-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2322"],"URL":"https:\/\/doi.org\/10.1186\/s12872-021-02322-w","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,20]]},"assertion":[{"value":"12 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethics committee of Beijing Chaoyang Hospital, Capital Medical University and performed in accordance with the ethical standers laid down in the 1964 Declaration of Helsinki and its later amendments. Written informed consents were obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"507"}}